Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | 0 | uM | 2 | 5000.00 | 2676.73 | 5471.00 | 5407.50 | 1.0117 | 1.0231 | |
MDA-MB-231 | 0 | uM | 2 | 5000.00 | 2676.73 | 5768.00 | 5407.50 | 1.0667 | 1.1314 | |
MDA-MB-231 | 0 | uM | 2 | 5000.00 | 2676.73 | 5471.00 | 5407.50 | 1.0117 | 1.0231 | |
MDA-MB-231 | 0 | uM | 2 | 5000.00 | 2676.73 | 5484.00 | 5407.50 | 1.0141 | 1.0279 | |
MDA-MB-231 | Etoposide | 0.01 | uM | 2 | 5000.00 | 2676.73 | 5363.00 | 5407.50 | 0.9918 | 0.9838 |
MDA-MB-231 | Etoposide | 0.31623 | uM | 2 | 5000.00 | 2676.73 | 4218.00 | 5407.50 | 0.7800 | 0.5656 |
MDA-MB-231 | PLX-4720 | 0.1 | uM | 2 | 5000.00 | 2676.73 | 5389.00 | 5407.50 | 0.9966 | 0.9933 |
MDA-MB-231 | Nilotinib | 0.01 | uM | 2 | 5000.00 | 2676.73 | 5464.00 | 5407.50 | 1.0104 | 1.0206 |
MDA-MB-231 | Nilotinib | 0.1 | uM | 2 | 5000.00 | 2676.73 | 5566.00 | 5407.50 | 1.0293 | 1.0578 |
MDA-MB-231 | Etoposide | 19.9526 | uM | 2 | 5000.00 | 2676.73 | 2305.00 | 5407.50 | 0.4263 | -0.1370 |
MDA-MB-231 | PLX-4720 | 0.01 | uM | 2 | 5000.00 | 2676.73 | 5261.00 | 5407.50 | 0.9729 | 0.9466 |
MDA-MB-231 | PLX-4720 | 3.1623 | uM | 2 | 5000.00 | 2676.73 | 5368.00 | 5407.50 | 0.9927 | 0.9856 |
MDA-MB-231 | Nilotinib | 10 | uM | 2 | 5000.00 | 2676.73 | 2501.00 | 5407.50 | 0.4625 | -0.0647 |
MDA-MB-231 | NVP-TAE684 | 0.0016596 | uM | 2 | 5000.00 | 2676.73 | 5435.00 | 5407.50 | 1.0051 | 1.0100 |
MDA-MB-231 | Nilotinib | 1 | uM | 2 | 5000.00 | 2676.73 | 4947.00 | 5407.50 | 0.9148 | 0.8320 |
MDA-MB-231 | NVP-TAE684 | 0.1 | uM | 2 | 5000.00 | 2676.73 | 5284.00 | 5407.50 | 0.9772 | 0.9550 |
MDA-MB-231 | PLX-4720 | 10 | uM | 2 | 5000.00 | 2676.73 | 5124.00 | 5407.50 | 0.9476 | 0.8966 |
MDA-MB-231 | Nilotinib | 19.9526 | uM | 2 | 5000.00 | 2676.73 | 1782.00 | 5407.50 | 0.3295 | -0.3304 |
MDA-MB-231 | 0 | uM | 2 | 5000.00 | 2676.73 | 5379.00 | 5407.50 | 0.9947 | 0.9896 | |
MDA-MB-231 | NVP-TAE684 | 3.1623 | uM | 2 | 5000.00 | 2676.73 | 2744.00 | 5407.50 | 0.5074 | 0.0248 |
MDA-MB-231 | Etoposide | 0.0033113 | uM | 2 | 5000.00 | 2676.73 | 5511.00 | 5407.50 | 1.0191 | 1.0377 |
MDA-MB-231 | PLX-4720 | 19.9526 | uM | 2 | 5000.00 | 2676.73 | 4842.00 | 5407.50 | 0.8954 | 0.7937 |
MDA-MB-231 | Etoposide | 3.1623 | uM | 2 | 5000.00 | 2676.73 | 2730.00 | 5407.50 | 0.5049 | 0.0196 |
MDA-MB-231 | NVP-TAE684 | 10 | uM | 2 | 5000.00 | 2676.73 | 1517.00 | 5407.50 | 0.2805 | -0.4287 |
MDA-MB-231 | 0 | uM | 2 | 5000.00 | 2676.73 | 5427.00 | 5407.50 | 1.0036 | 1.0071 |